Browsing Tag
Upstream Bio
1 post
Upstream Bio gains FDA alignment for pivotal verekitug trials across asthma and nasal polyps
Upstream Bio sets Phase 3 plans for quarterly verekitug in severe asthma and CRSwNP. See what FDA alignment means for the biotech’s growth strategy.